Loading people...
Laura A. Lane is the Vice President and Head of Europe at Lilly Ventures, the venture capital arm of Eli Lilly & Company, based in London, UK. Prior to this role, she served as a Principal at Advent Life Sciences, where she supported a life sciences portfolio that achieved over 15 product approvals and more than 20 corporate exits. Her operational experience includes serving as Chief Operating Officer at Refeyn, Interim Chief Executive Officer at Aston Particle Technologies, and Co-founder and Chief Operating Officer at VirionHealth. Lane holds a PhD from the University of Cambridge and has accumulated over 15 years of experience spanning pharmaceutical development, technology transfer, and life sciences consulting. Her current focus centers on directing European venture capital strategy, executing direct biotechnology investments, and advancing early-stage drug discovery and medical technology innovations.
Laura A. Lane is a distinguished Principal at Advent Life Sciences, a premier transatlantic venture capital firm renowned for its deep expertise and strategic investments within the life sciences sector. In her pivotal role, Laura is instrumental in shaping the future of healthcare by identifying, evaluating, and nurturing promising new companies and technologies. Her work at Advent Life Sciences primarily involves new company formation and direct investments, with a keen focus on areas poised for significant impact and growth.
Laura's investment focus spans a broad spectrum of life sciences innovation. She actively seeks opportunities in therapeutics, including novel drug discovery and development platforms that address unmet medical needs. Beyond pharmaceuticals, her expertise extends to medical devices, where she supports advancements that improve patient outcomes and healthcare delivery. Furthermore, Laura is deeply engaged in the burgeoning field of digital health, recognizing its transformative potential to revolutionize patient care, diagnostics, and health management through technology. Her comprehensive approach ensures Advent Life Sciences remains at the forefront of life sciences venture capital.
Prior to her tenure at Advent Life Sciences, Laura A. Lane built a robust career foundation that uniquely positions her for success in venture capital. She honed her strategic and analytical skills during her time as a consultant at Bain & Company, a global management consulting firm. This experience provided her with invaluable insights into business strategy, market analysis, and operational excellence across various industries. Academically, Laura holds a Ph.D. in Biophysics from Harvard University, a testament to her profound scientific understanding and commitment to rigorous research. This strong scientific background, combined with her strategic consulting experience, allows her to critically assess complex scientific innovations and their commercial viability.
While specific individual "notable investments" are often attributed to the firm as a whole, Laura A. Lane plays a crucial role in contributing to Advent Life Sciences' impressive portfolio. Her involvement helps identify and support companies that are developing cutting-edge solutions in areas like oncology, rare diseases, neurological disorders, and advanced medical technologies. Through her diligent work, Laura helps ensure that Advent Life Sciences continues to back ventures that have the potential to deliver significant therapeutic and economic value, ultimately improving lives globally. Her dedication to fostering innovation makes her a key asset to the Advent Life Sciences team and the broader life sciences investment community.
Laura A. Lane is a Principal at Advent Life Sciences, a leading transatlantic venture capital firm. She specializes in identifying and investing in new company formations and innovative technologies within the life sciences sector.
Laura A. Lane invests in a range of life sciences areas, including therapeutics, medical devices, and digital health. Her focus is on groundbreaking innovations that address critical healthcare needs.
Laura A. Lane works as a Principal at Advent Life Sciences, a prominent venture capital firm with a focus on the life sciences industry.
